Tweed has received authorization from Health Canada to begin the production of cannabis extracts.
The company says it be using pharmaceutical grade extraction methods to produce purified cannabis derivatives, and will have a variety of strain specific products available right away. In addition to this recent authorization, Tweed also received approval on new drying, trimming, processing, and extraction rooms.
“Our customers have come to expect the best from Tweed’s product lines,” said Bruce Linton, the Company’s Chairman and CEO. “The major advantage that comes with commercial scale is that you can provide products to customers that they couldn’t make themselves at home.”
Telling BNN that Tweed also expects to expand internationally, Bruce Linton said, “Canada has done the best job with creating the regulations, and I believe that Tweed has done one of the best jobs of pursing success in those rules.”